Shares of Zscaler Inc (NASDAQ: ZS) spiked close to 11% in Thursday’s after-hours session, after the company reported upbeat quarterly results, with earnings and revenue beating Street expectations.
BMO Capital Markets On Zscaler
Morgan Stanley upgraded Regeneron Pharmaceuticals Inc’s (NASDAQ:REGN) to Overweight from Equal Weight with a price target of $851, up from $625. The analyst…
Shares of DocuSign Inc. (NASDAQ: DOCU) jumped more than 17% in Friday’s pre-market after the company reported better-than-expected quarterly results and raised its full-year billings outlook.
Here's what analysts had to say:
The recovery seen after the mid-June lows led analysts and investors into believing that the market may have bottomed. It was not to be, though. What Happened: Following a nice rebound that lasted until mid-August, the market has hit another rough patch amid interest rate worries.
An analyst now anticipates more pain ahead in the coming months.